Skip to content
  • Mediacenter
  • Literature Database
  • Investor News
  • Careers
  • Get in Contact
International (English)
Locale
CytoSorbents Europe GmbH
International (English)
Locale
Hotline
  • COVID-19
    • Global decision support
  • The Therapy
    • Therapeutic aspects
    • Ticagrelor and Rivaroxaban
    • Fields of application for the CytoSorb Therapy
    • CytoScore in septic shock
    • Background
    • Product safety
    • Testimonials
  • The Studies
    • Multicenter Studies
    • Monocenter studies
    • The CytoSorb-Registry
    • Case of the week Submission
  • The Adsorber
    • Setup of CytoSorb
    • Usage and Application
    • Technical data
    • Q&A
  • Events
    • Event review
  • Support
    • Mediacenter
    • Reimbursement & Coding of CytoSorb Therapy
    • Newsletter Registration
    • Hotline
  • About us
    • Corporation Management
    • CytoSorbents worldwide
    • Scientific partners
    • Careers
    • Get in Contact

CytoSorbents Symposium at the EuroELSO 2022

ISICEM 2022 CytoSorbents Symposium: Hemoadsorption with CytoSorb

Best Bits: Hemoadsorption with CytoSorb Satellite Symposium

Satellite Symposium at the DGFN 2021

Hemoadsorption with CytoSorb in critically ill patients – new data and clinical experiences

8th International CytoSorb Users Meeting

Hemoadsorption with CytoSorb in various cardiac surgery indications

Role of CytoSorb hemoadsorption therapy in endocarditis patients

Hemoadsorption with CytoSorb in sepsis and COVID-19 patients – an update

Update on CytoSorb therapy in COVID-19 patients – INTERNATIONAL EXPERTS MEETING Intensive Care | Full Version

Multisystem inflammatory syndrome | English

  • 1
  • 2
  • 3
  • ...
  • 15
  • Next
CytoSorbents Europe GmbH
Facebook-f Twitter Linkedin Youtube

CytoSorbents Europe GmbH
Müggelseedamm 131
12587 Berlin

support(at)cytosorbents.com

©2022 CYTOSORBENTS EUROPE GMBH | ALL RIGHTS RESERVED

*Cytosorb Therapy is the use of the CytoSorb adsorber in conditions where elevated levels of Cytokines and/or Bilirubin and/or Myoglobin exist. CytoSorb can also be used intraoperatively for the removal of Ticagrelor and/or Rivaroxaban during Cardiopulmonary-Bypass.

  • Privacy Information
  • Data protection
  • Disclaimer
  • Imprint
CytoSorbents Europe GmbH
  • COVID-19
    • Global decision support
  • The Therapy
    • Therapeutic aspects
    • Ticagrelor and Rivaroxaban
    • Fields of application for the CytoSorb Therapy
    • CytoScore in septic shock
    • Background
    • Product safety
    • Testimonials
  • The Studies
    • Multicenter Studies
    • Monocenter studies
    • The CytoSorb-Registry
    • Case of the week Submission
  • The Adsorber
    • Setup of CytoSorb
    • Usage and Application
    • Technical data
    • Q&A
  • Events
    • Event review
  • Support
    • Mediacenter
    • Reimbursement & Coding of CytoSorb Therapy
    • Newsletter Registration
    • Hotline
  • About us
    • Corporation Management
    • CytoSorbents worldwide
    • Scientific partners
    • Careers
    • Get in Contact
APPLY TODAY
JOBS
International (English)
  • Privacy Policy
  • Data protection
  • Disclaimer
  • Imprint